DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Guggenheim Securities Initiates Coverage On 10x Genomics with Buy Rating

Guggenheim Securities analyst David Wastenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating.

Benzinga · 03/05/2020 16:39

Guggenheim Securities analyst David Wastenberg initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating.